** = Publikationen gelistet in SCI/SSCI/Pubmed
** Lichtenegger, S; Sonnleitner, ST; Saiger, S; Zauner, A; Hardt, M; Kleinhappl, B; Wagner, GE; Steinmetz, I
Anti-RBD immunoglobulin levels and their predictive value for SARS-CoV-2 neutralization.
Microbiol Spectr. 2025; e0214824
Doi: 10.1128/spectrum.02148-24
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Walder, S; Knabl, L; Poernbacher, R; Tschurtschenthaler, T; Hinterbichler, E; Sonnleitner, S; Muehlmann, V; Posch, W; Walder, G
Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants.
Front Immunol. 2023; 14:1165769
Doi: 10.3389/fimmu.2023.1165769
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jäger, M; Sonnleitner, ST; Dichtl, S; Lafon, E; Diem, G; Walder, G; Lass-Flörl, C; Wilflingseder, D; Posch, W
Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees.
Front Immunol. 2022; 13:868361
Doi: 10.3389/fimmu.2022.868361
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Prelog, M; Jansen, B; Rodgarkia-Dara, C; Gietl, S; Schönegger, CM; Koblmüller, S; Sturmbauer, C; Posch, W; Almanzar, G; Jury, H; Loney, T; Tichy, A; Nowotny, N; Walder, G
Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients.
Transbound Emerg Dis. 2022; 69(3):1596-1605
Doi: 10.1111/tbed.14130
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Prelog, M; Sonnleitner, S; Hinterbichler, E; Halbfurter, H; Kopecky, DBC; Almanzar, G; Koblmüller, S; Sturmbauer, C; Feist, L; Horres, R; Posch, W; Walder, G
Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
Nat Commun. 2022; 13(1):2560
Doi: 10.1038/s41467-022-30163-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Sonnleitner, S; Hinterbichler, E; Halbfurter, H; Kopecky, DBC; Koblmüller, S; Sturmbauer, C; Posch, W; Walder, G
The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro.
Virol Sin. 2022; 37(2):198-207
Doi: 10.1016/j.virs.2022.01.029
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gietl, S; Schönegger, CM; Falk, M; Weiler, S; Obererlacher, S; Jansen, B; Sonnleitner, ST; Walder, G
Home quarantine in COVID-19: A study on 50 consecutive patients in Austria.
Clin Med (Lond). 2021; 21(1):e9-e13
Doi: 10.7861/clinmed.2020-0787
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Dorighi, J; Jansen, B; Schönegger, C; Gietl, S; Koblmüller, S; Sturmbauer, C; Posch, W; Walder, G
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value.
Virol J. 2021; 18(1):71
Doi: 10.1186/s12985-021-01542-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Dorighi, J; Jansen, B; Schönegger, C; Gietl, S; Koblmüller, S; Sturmbauer, C; Posch, W; Walder, G
Correction to: An in vitro model for assessment of SARS‑CoV‑2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS‑CoV‑2 from oropharyngeal swabs correlates negatively with Cq value.
Virol J. 2021; 18(1):82
Doi: 10.1186/s12985-021-01558-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Margos, G; Wex, F; Simeoni, J; Zelger, R; Schmutzhard, E; Lass-Flörl, C; Walder, G
Human seroprevalence against Borrelia burgdorferi sensu lato in two comparable regions of the eastern Alps is not correlated to vector infection rates.
Ticks Tick Borne Dis. 2015; 6(3):221-7
Doi: 10.1016/j.ttbdis.2014.12.006
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Fritz, J; Bednarska, M; Baumgartner, R; Simeoni, J; Zelger, R; Schennach, H; Lass-Flörl, C; Edelhofer, R; Pfister, K; Milhakov, A; Walder, G
Risk assessment of transfusion-associated babesiosis in Tyrol: appraisal by seroepidemiology and polymerase chain reaction.
Transfusion. 2014; 54(7):1725-32
Doi: 10.1111/trf.12606
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Lundström, J; Baumgartner, R; Simeoni, J; Schennach, H; Zelger, R; Prader, A; Schmutzhard, E; Nowotny, N; Walder, G
Investigations on California serogroup orthobunyaviruses in the Tyrols: first description of Tahyna virus in the Alps.
Vector Borne Zoonotic Dis. 2014; 14(4):272-7
Doi: 10.1089/vbz.2013.1360
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Simeoni, J; Lang, S; Dobler, G; Speck, S; Zelger, R; Schennach, H; Lass-Flörl, C; Walder, G
Spotted fever group--Rickettsiae in the Tyrols: evidence by seroepidemiology and PCR.
Zoonoses Public Health. 2013; 60(4):284-90
Doi: 10.1111/j.1863-2378.2012.01534.x
Web of Science
PubMed
FullText
FullText_MUG
** Sonnleitner, ST; Simeoni, J; Schmutzhard, E; Niedrig, M; Ploner, F; Schennach, H; Dierich, MP; Walder, G
Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors.
Eur J Clin Microbiol Infect Dis. 2012; 31(1):77-81
Doi: 10.1007/s10096-011-1279-x
Web of Science
PubMed
FullText
FullText_MUG